All Stories

  1. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge

    Article • Journal of Virology, September 2017, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  2. Drug analog inhibition of indoleamine 2,3-dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection

    Article • Journal of Leukocyte Biology, May 2014, Society for Leukocyte Biology

    Stephen Mark Tompkins

  3. Indoleamine 2,3-Dioxygenase (IDO) Activity During the Primary Immune Response to Influenza Infection Modifies the Memory T Cell Response to Influenza Challenge

    Article • Viral Immunology, April 2014, Mary Ann Liebert Inc

    Stephen Mark Tompkins, Professor Ralph A Tripp

  4. Novel H7N9 Influenza Virus Shows Low Infectious Dose, High Growth Rate, and Efficient Contact Transmission in the Guinea Pig Model

    Article • Journal of Virology, November 2013, ASM Journals

    Stephen Mark Tompkins

  5. Targeting Cell Division Cycle 25 Homolog B To Regulate Influenza Virus Replication

    Article • Journal of Virology, October 2013, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  6. A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

    Article • Journal of Virology, July 2013, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  7. Antiviral Responses by Swine Primary Bronchoepithelial Cells Are Limited Compared to Human Bronchoepithelial Cells Following Influenza Virus Infection

    Article • PLoS ONE, July 2013, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  8. Efficacy of Parainfluenza Virus 5 Mutants Expressing Hemagglutinin from H5N1 Influenza A Virus in Mice

    Article • Journal of Virology, June 2013, ASM Journals

    Hualan Chen, Stephen Mark Tompkins

  9. Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs

    Article • PLoS ONE, June 2013, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  10. Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection

    Article • PLoS ONE, June 2013, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  11. Bat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment

    Article • Influenza and Other Respiratory Viruses, May 2013, Wiley

    Stephen Mark Tompkins, Professor Ralph A Tripp

  12. Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice

    Article • Journal of General Virology, April 2013, Society for General Microbiology

    Stephen Mark Tompkins, Professor Ralph A Tripp

  13. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

    Article • Journal of General Virology, April 2013, Society for General Microbiology

    Stephen Mark Tompkins, Professor Ralph A Tripp

  14. Experimental Infection of European Starlings (Sturnus vulgaris) and House Sparrows (Passer domesticus) with Pandemic 2009 H1N1 and Swine H1N1 and H3N2 Triple Reassortant Influenza Viruses

    Article • Journal of Wildlife Diseases, April 2013, Wildlife Disease Association

    Stephen Mark Tompkins

  15. Single-Dose Vaccination of a Recombinant Parainfluenza Virus 5 Expressing NP from H5N1 Virus Provides Broad Immunity against Influenza A Viruses

    Article • Journal of Virology, March 2013, ASM Journals

    Stephen Mark Tompkins

  16. Adenovirus 36, adiposity, and bone strength in late‐adolescent females

    Article • Journal of Bone and Mineral Research, February 2013, Oxford University Press (OUP)

    Stephen Mark Tompkins, Professor Ralph A Tripp

  17. Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses

    Article • Future Virology, January 2013, Future Medicine

    Stephen Mark Tompkins

  18. Targeting Organic Anion Transporter 3 with Probenecid as a Novel Anti-Influenza A Virus Strategy

    Article • Antimicrobial Agents and Chemotherapy, November 2012, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  19. Recombinant Parainfluenza Virus 5 Expressing Hemagglutinin of Influenza A Virus H5N1 Protected Mice against Lethal Highly Pathogenic Avian Influenza Virus H5N1 Challenge

    Article • Journal of Virology, October 2012, ASM Journals

    Stephen Mark Tompkins

  20. Recombinant Parainfluenza Virus 5 Vaccine Encoding the Influenza Virus Hemagglutinin Protects against H5N1 Highly Pathogenic Avian Influenza Virus Infection following Intranasal or Intramuscular Vaccination of BALB/c Mice

    Article • Journal of Virology, October 2012, ASM Journals

    Stephen Mark Tompkins

  21. Domestic Cats Are Susceptible to Infection With Low Pathogenic Avian Influenza Viruses From Shorebirds

    Article • Veterinary Pathology, June 2012, SAGE Publications

    Stephen Mark Tompkins

  22. Low Pathogenic Avian Influenza Isolates from Wild Birds Replicate and Transmit via Contact in Ferrets without Prior Adaptation

    Article • PLoS ONE, June 2012, PLOS

    Stephen Mark Tompkins

  23. MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication

    Article • PLoS ONE, May 2012, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  24. Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose

    Article • Vaccine, April 2012, Elsevier

    Stephen Mark Tompkins, Professor Ralph A Tripp

  25. A Multiplex Suspension Array for Screening of Carbohydrate Binding Proteins and Influenza

    Article • Biophysical Journal, January 2012, Elsevier

    Stephen Mark Tompkins

  26. Surveillance of feral cats for influenza A virus in North Central Florida

    Article • Influenza and Other Respiratory Viruses, December 2011, Wiley

    Stephen Mark Tompkins, Professor Ralph A Tripp

  27. Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

    Article • PLoS ONE, July 2011, PLOS

    Stephen Mark Tompkins, Dr Graeme E Price

  28. Avian Influenza Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by Sialic Acid α2,3 Residues

    Article • PLoS ONE, June 2011, PLOS

    Stephen Mark Tompkins, Professor Ralph A Tripp

  29. Comparative Pathology in Ferrets Infected with H1N1 Influenza A Viruses Isolated from Different Hosts

    Article • Journal of Virology, May 2011, ASM Journals

    Stephen Mark Tompkins, Professor Ralph A Tripp

  30. Corrigendum to “Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection” [Virology 399 (2010) 280–289]

    Article • Virology, May 2011, Elsevier

    Stephen Mark Tompkins

  31. Aerosol Inoculation with a Sub-lethal Influenza Virus Leads to Exacerbated Morbidity and Pulmonary Disease Pathogenesis

    Article • Viral Immunology, April 2011, Mary Ann Liebert Inc

    Stephen Mark Tompkins, Professor Ralph A Tripp

  32. Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice

    Article • Vaccine, March 2011, Elsevier

    Stephen Mark Tompkins, Professor Ralph A Tripp

  33. One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles

    Article • The Analyst, January 2011, Royal Society of Chemistry

    Stephen Mark Tompkins, Professor Ralph A Tripp

  34. Passage of low-pathogenic avian influenza (LPAI) viruses mediates rapid genetic adaptation of a wild-bird isolate in poultry

    Article • Archives of Virology, January 2011, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  35. Application of RNA Interference to Viral Diseases

    Article • November 2010, Wiley

    Stephen Mark Tompkins, Professor Ralph A Tripp

  36. Genetic control of immune responses to influenza A matrix 2 protein (M2)

    Article • Vaccine, August 2010, Elsevier

    Stephen Mark Tompkins

  37. Immunogenicity of Avian H5N1 Influenza Virus Recombinant Vaccines in Cats

    Article • Viral Immunology, April 2010, Mary Ann Liebert Inc

    Stephen Mark Tompkins

  38. Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection

    Article • Virology, April 2010, Elsevier

    Stephen Mark Tompkins

  39. Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks

    Article • Archives of Virology, July 2009, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  40. Therapeutic Applications of RNAi for Silencing Virus Replication

    Article • January 2009, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  41. Animal Models for Evaluation of Influenza Vaccines

    Article • January 2009, Springer Science + Business Media

    Stephen Mark Tompkins, Professor Ralph A Tripp

  42. A humanized anti-M2 scFv shows protective in vitro activity against influenza

    Article • Protein Engineering Design and Selection, October 2008, Oxford University Press (OUP)

    Stephen Mark Tompkins

  43. Response to Protocol Review Scenario: Why use ferrets?

    Article • Lab Animal, August 2008, Springer Science + Business Media

    Stephen Mark Tompkins

  44. Virally Encoded MicroRNA (miRNA) Candidates for Gene Silencing

    Article • July 2008, Taylor & Francis

    Stephen Mark Tompkins, Professor Ralph A Tripp

  45. Hydrophobic Inactivation of Influenza Viruses Confers Preservation of Viral Structure with Enhanced Immunogenicity

    Article • Journal of Virology, February 2008, ASM Journals

    Stephen Mark Tompkins

  46. Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge

    Article • Virology, May 2007, Elsevier

    Stephen Mark Tompkins, Professor Ralph A Tripp

  47. Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

    Article • Emerging Infectious Diseases, March 2007, Centers for Disease Control and Prevention (CDC)

    Stephen Mark Tompkins

  48. Protection against lethal influenza virus challenge by RNA interferencein vivo

    Article • Proceedings of the National Academy of Sciences, June 2004, Proceedings of the National Academy of Sciences

    Stephen Mark Tompkins

  49. An array of possibilities for multiple sclerosis

    Article • Nature Medicine, May 2002, Springer Science + Business Media

    Stephen Mark Tompkins

  50. Theiler's Virus‐Mediated Autoimmunity

    Article • Annals of the New York Academy of Sciences, April 2002, Wiley

    Stephen Mark Tompkins

  51. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

    Article • Cell, June 1991, Elsevier

    Stephen Mark Tompkins